Technology

banner image

Novavax Covid Jab Highly Effective, But Not Against South Africa Variant

US biotech firm Novavax said Thursday its two-shot Covid-19 vaccine showed an overall efficacy of 89.3 percent in a major Phase 3 clinical trial in Britain, and remained highly effective against a...

from NDTV News - World-news https://ift.tt/36lyTbO
Novavax Covid Jab Highly Effective, But Not Against South Africa Variant Novavax Covid Jab Highly Effective, But Not Against South Africa Variant Reviewed by YFT News on January 28, 2021 Rating: 5

No comments:

Powered by Blogger.